Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-12-05

Clinical Trial Update: Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease [NA]

View source ↗

Summary

The study evaluating nasal calcitonin for bone mineral loss in children and adolescents with inflammatory bowel disease has completed. The conditions studied in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nasal Calcitonin (Calcitonin (salmon))

Snippet

Sponsor: Boston Children's Hospital | Conditions: Ulcerative Colitis, Crohn's Disease | NA | Status: COMPLETED